data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
NeuroMetrix
(NASDAQ:NURO)
3.70
0.16[4.52%]
At close: Jun 24
3.73
0.0300[0.81%]
After Hours: 4:09PM EDT
Day High/Low3.58 - 4
52 Week High/Low2.7 - 38.75
Open / Close3.66 / 3.7
Float / Outstanding7.1M / 7.1M
Vol / Avg.115.5K / 1.6M
Mkt Cap26.4M
P/E-
50d Avg. Price3.68
Div / Yield-
Payout Ratio-
EPS-0.14
Total Float7.1M

NeuroMetrix (NASDAQ:NURO), Quotes and News Summary

NeuroMetrix (NASDAQ: NURO)

Day High/Low3.58 - 4
52 Week High/Low2.7 - 38.75
Open / Close3.66 / 3.7
Float / Outstanding7.1M / 7.1M
Vol / Avg.115.5K / 1.6M
Mkt Cap26.4M
P/E-
50d Avg. Price3.68
Div / Yield-
Payout Ratio-
EPS-0.14
Total Float7.1M
Benzinga - Sponsored
Benzinga - May 23, 2022, 3:57AM
Benzinga - May 20, 2022, 11:05AM
Benzinga - May 19, 2022, 2:37PM
Benzinga - May 19, 2022, 2:31PM
Benzinga - May 19, 2022, 10:41AM
Benzinga - May 19, 2022, 10:22AM
Benzinga - May 19, 2022, 9:08AM
Benzinga - Apr 26, 2022, 7:13AM
Benzinga - Apr 25, 2022, 1:37PM
Benzinga - Feb 24, 2022, 2:21PM
Benzinga - Feb 24, 2022, 9:03AM
Benzinga - Feb 14, 2022, 12:37PM
Benzinga - Jan 27, 2022, 7:18AM
Benzinga - Jan 21, 2022, 11:36AM
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-21
REV
Q1 2022Est.ActualSurprise
EPS-0.140
REV2.302M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

NeuroMetrix Questions & Answers

Q
How do I buy NeuroMetrix (NURO) stock?
A

You can purchase shares of NeuroMetrix (NASDAQ: NURO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are NeuroMetrix's (NURO) competitors?
Q
What is the target price for NeuroMetrix (NURO) stock?
A

The latest price target for NeuroMetrix (NASDAQ: NURO) was reported by Rodman & Renshaw on Tuesday, June 28, 2016. The analyst firm set a price target for 4.50 expecting NURO to rise to within 12 months (a possible 21.62% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for NeuroMetrix (NURO)?
A

The stock price for NeuroMetrix (NASDAQ: NURO) is $3.7 last updated June 24, 2022, 8:00 PM UTC.

Q
Does NeuroMetrix (NURO) pay a dividend?
A

There are no upcoming dividends for NeuroMetrix.

Q
When is NeuroMetrix (NASDAQ:NURO) reporting earnings?
A

NeuroMetrix’s Q2 earnings are confirmed for Thursday, July 21, 2022.

Q
Is NeuroMetrix (NURO) going to split?
A

There is no upcoming split for NeuroMetrix.

Q
What sector and industry does NeuroMetrix (NURO) operate in?
A

NeuroMetrix is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.